GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice
Carmelo Quarta(Université de Bordeaux), Timo D. Müller(Anton Paar (Austria)), Gustav Colldén(Inserm), Aimée Bastidas-Ponce(Universidad Nacional Autónoma de México), Diego Pérez–Tilve(University of Cincinnati Medical Center), Fanny Lalloyer(Inserm), Nathalie Hennuyer(Inserm), Megan E. Capozzi(Duke University), Daniela Liśkiewicz(Helmholtz Zentrum München), Susanna M. Hofmann(Helmholtz Zentrum München), Patrick J. Knerr(Novo Nordisk (United States)), Barent DuBois(Novo Nordisk (United States)), Felix Klingelhuber(Deutsches Diabetes-Zentrum e.V.), Gandhari Maity(Helmholtz Zentrum München), Annette Feuchtinger(Helmholtz Zentrum München), Aaron Novikoff(Deutsches Diabetes-Zentrum e.V.), Arkadiusz Liśkiewicz(Deutsches Diabetes-Zentrum e.V.), Brian Finan(Eli Lilly (United States)), Alex Harger(Helmholtz Zentrum München), Daniel J. Drucker(University of Toronto), Cristina García‐Cáceres(Helmholtz Zentrum München), Eric Baugé(Inserm), Heiko Lickert(Helmholtz Zentrum München), Perla Cota(Deutsches Diabetes-Zentrum e.V.), Jon Douros(Novo Nordisk (United States)), Bin Yang, Kerstin Stemmer(University of Augsburg), Jonathan E. Campbell(Duke University), Konxhe Kulaj(Helmholtz Zentrum München), Richard D. DiMarchi(Indiana University Bloomington), Stephan Herzig(Heidelberg University), Natalie Krahmer(Helmholtz Zentrum München), Mostafa Bakhti(Helmholtz Zentrum München), Gerald Grandl(Helmholtz Zentrum München), Christoffer Clemmensen(University of Copenhagen), Qian Zhang(Jiangsu Academy of Agricultural Sciences), Sneha Prakash(Helmholtz Zentrum München), Miguel A. Sánchez-Garrido(Instituto Maimónides de Investigación Biomédica de Córdoba), Matthias H. Tschöp(Helmholtz Zentrum München), Bart Staels(Inserm)
Cited by 38
Related Papers
Circulating Ghrelin Levels Are Decreased in Human Obesity
|Diabetes|2001|2k
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
|Journal of Hepatology|2014|1.5k
Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1
|Journal of Biological Chemistry|1999|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Anti-obesity drug discovery: advances and challenges
|Nature Reviews Drug Discovery|2021|950